AQST

Aquestive Therapeutics, Inc. NGM · AQST

$4.12 +0.18 (+4.57%)

Neutral · -0.33σ

+ Compare Open in Sniper

Valuation

Market cap $0.5B

P/E (ttm) —

Forward P/E -9.2

Beta (5y) 1.45

Shares out 125.5M

Div yield —

Profitability & returns

ROE —

Net margin -137.1%

FCF margin -51.1%

Debt / equity —

Trading information

Last price $4.12

Day range $3.81 – $4.16

52-wk range $2.93 – $5.18

Avg volume 1.8M

RSI (2) 82.3

Trend zone Neutral

52-week range · today's price

$2.93$5.18

Company

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Exchange NGM

Next earnings 2026-08-11

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; S…